Zhu Jie, Yang Jing, Luo Yunzi
Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin 300072, China.
Sheng Wu Gong Cheng Xue Bao. 2019 Dec 25;35(12):2350-2366. doi: 10.13345/j.cjb.190277.
Intestinal bacteria interact closely with human health and diseases. With the development of high-throughput sequencing technologies, researchers have discovered the potential of intestinal bacteria in the diagnosis and treatment of diseases. Meanwhile, synthetic biology strategies are applied to engineer these bacteria for clinical applications. These engineered intestinal microbial are constructed by designing editing tools and feedback loops to gain functions of diagnose or targeted therapy. Consequently, these engineered bacteria are capable of sensing, calculating and responding to the environment. In this review, we summarize the recent advances in engineered intestinal bacteria in disease diagnosis and treatment. Furthermore, we also discuss the current status and future prospect of the engineered intestinal bacteria regarding their clinical applications, market, and safety issues.
肠道细菌与人类健康和疾病密切相关。随着高通量测序技术的发展,研究人员发现了肠道细菌在疾病诊断和治疗方面的潜力。与此同时,合成生物学策略被应用于对这些细菌进行工程改造以用于临床应用。这些经过工程改造的肠道微生物通过设计编辑工具和反馈回路来构建,以获得诊断或靶向治疗功能。因此,这些工程菌能够感知、计算并对环境做出反应。在本综述中,我们总结了工程化肠道细菌在疾病诊断和治疗方面的最新进展。此外,我们还讨论了工程化肠道细菌在临床应用、市场及安全问题方面的现状和未来前景。